Inhibition of tumor angiogenesis by TTF1 from extract of herbal medicine

World Journal of Gastroenterology

Volumn 17, Issue 44, 2011, Pages 4875-4882

  Liu, Chao ^a   Li, Xiao Wan ^a   Cui, Li Min ^a   Li, Liang Chang ^a   Chen, Li Yan ^a   Zhang, Xue Wu ^a  

^a YANBIAN UNIVERSITY   (China)

Author keywords

Chinese herbal medicine; Inhibition; Sorbaria sorbifolia; TTF1; Tumor angiogenesis

Indexed keywords

5,2,4' TRIHYDROXY 6,7,5' TRIMETHOXYFLAVONE; APIGENIN; CD34 ANTIGEN; CYCLOOXYGENASE 2; FIBROBLAST GROWTH FACTOR 2; HYPOXIA INDUCIBLE FACTOR 1ALPHA; MESSENGER RNA; PLANT EXTRACT; UNCLASSIFIED DRUG; VASCULOTROPIN; VASCULOTROPIN C;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIANGIOGENIC ACTIVITY; ARTICLE; CANCER INHIBITION; CHORIOALLANTOIS; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOWN REGULATION; DRUG STRUCTURE; EMBRYO; HERBAL MEDICINE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIVER CANCER; MOUSE; NONHUMAN; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; SORBARIA SORBIFOLIA; STATISTICAL SIGNIFICANCE; TREATMENT DURATION; WESTERN BLOTTING;

EID: 83155187286     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v17.i44.4875     Document Type: Article

References (20)

1. Ferrara N, Kerbel RS. Angiogenesis as a therapeutic target. Nature 2005; 438: 967-974
2. Folkman J. Antiangiogenesis in cancer therapy--endostatin and its mechanisms of action. Exp Cell Res 2006; 312: 594-607
3. Bagli E, Stefaniotou M, Morbidelli L, Ziche M, Psillas K, Murphy C, Fotsis T. Luteolin inhibits vascular endothelial growth factor-induced angiogenesis; inhibition of endothelial cell survival and proliferation by targeting phosphatidylinositol 3'-kinase activity. Cancer Res 2004; 64: 7936-7946
4. Gamble JR, Xia P, Hahn CN, Drew JJ, Drogemuller CJ, Brown D, Vadas MA. Phenoxodiol, an experimental anticancer drug, shows potent antiangiogenic properties in addition to its antitumour effects. Int J Cancer 2006; 118: 2412-2420
5. Mirzoeva S, Kim ND, Chiu K, Franzen CA, Bergan RC, Pelling JC. Inhibition of HIF-1 alpha and VEGF expression by the chemopreventive bioflavonoid apigenin is accompanied by Akt inhibition in human prostate carcinoma PC3-M cells. Mol Carcinog 2008; 47: 686-700
6. Chen Y, Li XX, Xing NZ, Cao XG. Quercetin inhibits choroidal and retinal angiogenesis in vitro. Graefes Arch Clin Exp Ophthalmol 2008; 246: 373-378
7. Singh RP, Gu M, Agarwal R. Silibinin inhibits colorectal cancer growth by inhibiting tumor cell proliferation and angiogenesis. Cancer Res 2008; 68: 2043-2050
8. Lu N, Gao Y, Ling Y, Chen Y, Yang Y, Gu HY, Qi Q, Liu W, Wang XT, You QD, Guo QL. Wogonin suppresses tumor growth in vivo and VEGF-induced angiogenesis through inhibiting tyrosine phosphorylation of VEGFR2. Life Sci 2008; 82: 956-963
9. Zhong Y, Krisanapun C, Lee SH, Nualsanit T, Sams C, Peungvicha P, Baek SJ. Molecular targets of apigenin in colorectal cancer cells: involvement of p21, NAG-1 and p53. Eur J Cancer 2010; 46: 3365-3374
10. Zhang X, Zhang Y, Guan L, Quan Y, Sun Q. [Study on extraction and isolation of active constituents from Sorbaria sorbifolia and antitumor effect of the constituents in vivo]. Zhong Yao Cai 2004; 27: 36-38
11. Zhang XW, Cui CX, Chen LY. [Inhibition of Sorbaria sorbifolia on proliferarion of hepatoma HepG-2 cell line]. Zhong Yao Cai 2007; 30: 681-684
12. Zhang XW, Sun Q, Jin M, Piao CM, Li LH. [Effect of Sorbaria Sorbifolia extract on anti-oxidative activities in rats with precancerosis induced by diethylnitrosamine]. Zhong Xi Yi Jie He Xue Bao 2003; 1: 47-50
13. Zhang XW, Zhang XB, Quan JS, Shen MH, Jin HL. Inhibitory effects of sorbaria sorbifolia on den-induced precancerous hepatic foci and its antioxidative activities in rats. China J Cancer Prev Treat 2003; 10: 1137-1140
14. Wu JM, Lu Y, Gao M, Zhang WW. The advances of angiogenesis assay models. Chin Pharmacol Bull 2008; 24: 11-14
15. Weidner N. Current pathologic methods for measuring intratumoral microvessel density within breast carcinoma and other solid tumors. Breast Cancer Res Treat 1995; 36: 169-180
16. Pandya NM, Dhalla NS, Santani DD. Angiogenesis--a new target for future therapy. Vascul Pharmacol 2006; 44: 265-274
17. Chen QJ, Zhang MZ, Wang LX. Gensenoside Rg3 inhibits hypoxia-induced VEGF expression in human cancer cells. Cell Physiol Biochem 2010; 26: 849-858
18. Talar-Wojnarowska R, Gasiorowska A, Olakowski M, Lekstan A, Lampe P, Smolarz B, Romanowicz-Makowska H, Kulig A, Malecka-Panas E. Vascular endothelial growth factor (VEGF) genotype and serum concentration in patients with pancreatic adenocarcinoma and chronic pancreatitis. J Physiol Pharmacol 2010; 61: 711-716
19. Han YD, Hong YK, Kang JG, Choi YJ, Park CH. Relation of the expression of cyclooxygenase-2 in colorectal adenomas and adenocarcinomas to angiogenesis and prognosis. J Korean Soc Coloproctol 2010; 26: 339-346
20. Zhang X, Ma C, Guan L, Quan Y. [Experimental study on Sorbaria sorbifolia extract against chronic liver damage in rats]. Zhong Yao Cai 2004; 27: 751-753